Abstract:Plasmodium vivax serological exposure markers (SEMs) have emerged as promising tools for the actionable surveillance and implementation of targeted interventions to accelerate malaria elimination. To determine the dynamic profiles of SEMs in current and past P . vivax infections, we screened and selected 11 P . vivax proteins from 210 putative proteins using protein arrays, with a set of serum samples obtained from patients with acute P . vivax and documented past P . vivax infections. Then we used a murine protein immune model to initially investigate the humoral and memory B cell response involved in the generation of long-lived antibodies. We show that of the 11 proteins, especially C-terminal 42-kDa region of P . vivax merozoite surface protein 1 (PvMSP1-42) induced longer-lasting long-lived antibodies, as these antibodies were detected in individuals infected with P . vivax in the 1960-1970s who were not re-infected until 2012. In addition, we provide a potential mechanism for the maintenance of long-lived antibodies after the induction of PvMSP1-42. The results indicate that PvMSP1-42 induces more CD73 + CD80 + memory B cells (MBCs) compared to P . vivax GPI-anchored micronemal antigen (PvGAMA), allowing IgG anti-PvMSP1-42 antibodies to be maintained for a long time. P . vivax serological exposure markers (SEMs) that reflect exposure to blood-stage P . vivax parasites, could play an important role in assessing progress towards malaria elimination. Serological surveillance can be a useful tool for identifying areas of high transmission intensity or hidden asymptomatic reservoirs, especially as malaria transmission declines. These immune responses can persist long after the clearance of blood-stage infection, making antibodies valuable markers for both past exposure and current infection status. Furthermore, gaining a better understanding of the host immune response to malaria, particularly regarding the induction and maintenance of high levels of circulating antibodies, is crucial for effective serological surveillance efforts. Using serum obtained in 2007 or 2012 from patients with acute P . vivax infection, 5-year, 12-year and 30-year recovery of P . vivax -infected patients we provide evidence that PvMSP1-42 induces long-lived anti-PvMSP1-42 antibodies. Then we used a murine protein immune model, show that more CD73 + CD80 + memory B cells, allowing IgG anti-PvMSP1-42 antibodies to be maintained for a long time (Fig 1). The results of this study represent an important step forward in our understanding of the host immune response to P . vivax blood stages, including the induction and maintenance of high levels of circulating antibodies. These findings may have important implications for the development of effective serological surveillance tools.

Identification of the Recombinant Plasmodium vivax Surface-Related Antigen as a Possible Immune Evasion Factor Against Human Splenic Fibroblasts by Targeting ITGB1

Plasmodium vivax spleen-dependent protein 1 and its role in extracellular vesicles-mediated intrasplenic infections

Plasma-derived extracellular vesicles from Plasmodium vivax patients signal spleen fibroblasts via NF-kB facilitating parasite cytoadherence

Functional and immunological mapping of domains of the reticulocyte binding protein, Plasmodium vivax PvRBP2a

Plasmodium vivax serological exposure markers: PvMSP1-42-induced humoral and memory B-cell response generates long-lived antibodies

Comparison of total immunoglobulin G antibody responses to different protein fragments of Plasmodium vivax Reticulocyte binding protein 2b

A Comparative Study of Natural Immune Responses Against Plasmodium Vivax C-Terminal Merozoite Surface Protein-1 (Pvmsp-1) and Apical Membrane Antigen-1 (Pvama-1) in Two Endemic Settings

Mass Spectrometry Identification of Biomarkers in Extracellular Vesicles From Plasmodium vivax Liver Hypnozoite Infections

Plasmodium vivax tryptophan-rich antigen reduces type I collagen secretion via the NF-κBp65 pathway in splenic fibroblasts

Profiling the antibody response of humans protected by immunization with Plasmodium vivax radiation-attenuated sporozoites

A systematic analysis of the human immune response to Plasmodium vivax

Plasmodium P36 determines host cell receptor usage during sporozoite invasion

An Immunomics Approach for the Analysis of Natural Antibody Responses to Plasmodium Vivax Infection.

Transferrin receptor 1 is a reticulocyte-specific receptor for Plasmodium vivax

Genetic Diversity and Natural Selection of Three Blood-Stage 6-Cys Proteins in Plasmodium Vivax Populations from the China-Myanmar Endemic Border.

Generation of an immortalized erythroid progenitor cell line from peripheral blood: A model system for the functional analysis of Plasmodium spp. invasion

Gene Structure and Expression of a Plasmodium Falciparum 220-Kda Protein Homologous to the Plasmodium Vivax Reticulocyte Binding Proteins.

Histamine releasing factor and elongation factor 1 alpha secreted via malaria parasites extracellular vesicles promote immune evasion by inhibiting specific T cell responses

Comparative transcriptomics reveal differential gene expression among Plasmodium vivax geographical isolates and implications on erythrocyte invasion mechanisms

Immune effect of T lymphocytes from Plasmodium vivax-infected patients stimulated by recombinant PvMSP1-19 antigen in vitro

ATG Ubiquitination Is Required for Circumsporozoite Protein to Subvert Host Innate Immunity Against Rodent Malaria Liver Stage